Lena Illert
Principal Investigator
Department of Hematology, Oncology and Stem-Cell Transplantation
Medical Center University of Freiburg
Hugstetter Straße 55
79106 Freiburg
- +49 761 270-32880
- lena.illert@uniklinik-freiburg.de
- Homepage
Current position
Managing Senior Physician (Geschäftsführende Oberärztin) Dpt. of Hematology, Oncology and Stem Cell-Transplantation, Medical Center University of Freiburg
Medical Co-Director Comprehensive Cancer Cancer Freiburg (CCCF)
Medical Co-Director Comprehensive Cancer Cancer Freiburg (CCCF)
Academic training
| 1996 - 2004 | Medical School, Georg-August-Universität Göttingen |
Advanced academic qualifications
| 2016 | Habilitation for Internal Medicine, subject: Signaling of oncogenic tyrosine kinases in lymphoma in leukemia, Technical University of Munich |
| 2004 | Doctorate: Autophagosome- and Lysosomebiogenesis of Lamp-2 deficient hepatocytes Georg-August-Universität Göttingen |
Postgraduate positions
| Since 02/19 | Managing Senior Physician, Medical Center University of Freiburg |
| Since 01/19 | Medical Co-Director of the Comprehensive Cancer Center Freiburg |
| 08-09/2018 | IO-Program (CAR-T-cells; ECT) Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA (Mentor: Anas Younes) |
| Since 2016 | Senior Physician, Medical Center University of Freiburg |
| Since 2015 | Junior Research Group Leader for “Signal transduction of oncogenic tyrosine kinases” |
| Since 2013 | Attending Physician, Medical Center University of Freiburg |
| 2007 - 2011 | Residency and Fellowship in Internal Medicine, Department of Hematology and Oncology, Technical University of Munich, Klinikum rechts der Isar |
| 2004 - 2007 | Postdoctoral Research Fellow at the Leukemogenesis Laboratory, Klinikum rechts der Isar, Technical University Munich |
Miscellaneous (Honors, Awards)
| 2020 - 2022 | Advanced Clinician Scientist Grant, German Society of Internal Medicine |
| 2019 | Young-Investigator-Award, German Society of Hematology Oncology (Senior author) |
| 04/2018 | Visiting Professorship Penn University, Philadelphia, USA |
| 2017 | Eleonore und Fritz Hodeige Preis |
| 2015 - 2018 | Brigitte-Schlieben-Langen-Fellow by the Government for Science, Research and Arts of Baden-Württemberg |
| 2015 | Mathilde-Wagner-Habilitation-Prize |
| 2015 | Young-Investigator-Award, DGHO (Senior author) |
| 2013 | EIRA-Mentoring Program of the University of Freiburg |
| 2009 - 2013 | Abstract Achievement Awards of the American and European Society of Hematology (ASH and EHA) |
| 2005 - 2007 | Travel awards for the American Society of Hematology (ASH) meeting |
| 1999 - 2001 | Fellowship German research Foundation (DFG) Graduate College 80 |
Publications listed in PubMed®
Publications (based on CRC1479 funding)
Kreutmair S, Lippert LJ, Klingeberg C, Albers-Leischner C, Yacob S, Shlyakhto V, Mueller T, Mueller-Rudorf A, Yu C, Gorantla SP, Miething C, Duyster J, Illert AL. NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis. Front Oncol. 2022 May 13;12:875117. doi: 10.3389/fonc.2022.875117.
Spohr C, Poggio T, Andrieux G, Schönberger K, Cabezas-Wallscheid N, Boerries M, Halbach S, Illert AL, Brummer T. Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo. Leukemia. 2022 Apr;36(4):970-982. doi: 10.1038/s41375-021-01490-0. Epub 2021 Dec 13.2021
Contact
